Poster (Scientific congresses and symposiums)
Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients
Maertens, Johan; R. Herbrecht; S. Fodil et al.
2025ESCMID Global 2025
Editorial reviewed
 

Files


Full Text
Poster_ESCMID_1.pdf
Author postprint (336.17 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
real world evidence; Anti-fungal; immunocompromised
Disciplines :
Microbiology
Author, co-author :
Maertens, Johan
R. Herbrecht
S. Fodil
De Voeght, Adrien  ;  Université de Liège - ULiège > GIGA > GIGA Immunobiology - Hematology ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
K. Delavigne
T. Liebregts
R. Rodriguez Veiga
J. De Greef
M. Uzunov
L. Vazquez10
O. Penack
A. Albasanz-Puig
M.C. Ngirabacu
V. Mehra
D. Teschner
L. Albert
C. Pfeifer
P. Brennan-Benson
K. Vanstraelen
E. Azoulay
More authors (10 more) Less
Language :
English
Title :
Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients
Original title :
[en] P2937 Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients
Publication date :
July 2025
Event name :
ESCMID Global 2025
Event organizer :
European Society of Clinical Microbiology and Infectious Diseases
Event date :
April 11-15, 2025
Audience :
International
Peer review/Selection committee :
Editorial reviewed
Available on ORBi :
since 04 November 2025

Statistics


Number of views
24 (7 by ULiège)
Number of downloads
29 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi